{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:24:02Z","timestamp":1760297042982},"publisher-location":"Chichester, UK","reference-count":12,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001416","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:16:04Z","timestamp":1069384564000},"source":"Crossref","is-referenced-by-count":8,"title":["Zonisamide add-on for drug-resistant partial epilepsy"],"prefix":"10.1002","author":[{"given":"DW","family":"Chadwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AG","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,22]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD001416-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/WNL.57.10.1774","article-title":"Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures","volume":"57","author":"Faught","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001416-BIB2|cit2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0920-1211(93)90011-U","article-title":"Zonisamide for add-on treatment of refractory partial epilepsy: a European double blind trial","volume":"15","author":"Schmidt","year":"1993","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001416-BIB3|cit3","unstructured":"Wilder BJ Ramsay RE Guterman A A double blind multicenter placebo controlled study of the efficacy of zonisamide in the treatment of complex partial seizures in medically refractory patients Internal report of the Dainippon Pharmaceutical Company 1986"},{"issue":"854","key":"10.1002\/14651858.CD001416-BIB4|cit4","first-page":"611","article-title":"Zonisamide: comparison with sodium valproate as additional treatment in refractory seizures","volume":"101","author":"Anderson","year":"1988","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD001416-BIB5|cit5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001416-BIB6|cit6","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"Effron","year":"1993"},{"key":"10.1002\/14651858.CD001416-BIB7|cit7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935 - 1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001416-BIB8|cit8","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models","author":"McCullagh","year":"1989"},{"issue":"5","key":"10.1002\/14651858.CD001416-BIB9|cit9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001416-BIB10|cit10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","article-title":"Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex","volume":"12","author":"Suzuki","year":"1992","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD001416-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.313.7066.1169","article-title":"The new antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"313","author":"Marson","year":"1996","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD001416-BIB12|cit12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1528-1157.1997.tb01251.x","article-title":"The new antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"38","author":"Marson","year":"1997","journal-title":"Epilepsia"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:02:47Z","timestamp":1628542967000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,22]]},"references-count":12,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001416","relation":{},"subject":[],"published":{"date-parts":[[2002,4,22]]}}}